CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-30 | Wang Xiaodong Director | Other disposition | −172,372 | 0 | ||
| 2023-11-14 | BAKER BROS. ADVISORS LP Director | Sale | −91,340 | $180.50 | $16.5M | 877,603 |
| 2023-11-14 | BAKER BROS. ADVISORS LP Director | Sale | −1,008,660 | $180.50 | $182.1M | 9,691,294 |
| 2023-07-31 | Lee Chan Henry SVP, General Counsel | Sale | −791 | $216.26 | $171K | 0 |
| 2023-07-03 | Wang Julia Aijun Chief Financial Officer | Sale | −472 | $179.55 | $85K | 0 |
| 2023-06-26 | Wang Lai Global Head of R&D | Sale | −1,103 | $181.91 | $201K | 5 |
| 2023-06-26 | Wang Lai Global Head of R&D | Sale | −5 | $183.15 | $916 | 0 |
| 2023-06-26 | Wu Xiaobin President, COO & GM China | Sale | −1,495 | $182.37 | $273K | 0 |
| 2023-06-23 | Wang Julia Aijun Chief Financial Officer | Sale | −840 | $182.85 | $154K | 0 |
| 2023-06-23 | Sanders Corazon (Corsee) D. Director | Sale 10b5-1 | −100 | $180.74 | $18K | 478 |
| 2023-06-23 | Sanders Corazon (Corsee) D. Director | Sale 10b5-1 | −478 | $182.65 | $87K | 0 |
| 2023-06-20 | Wang Lai Global Head of R&D | Sale | −1,325 | $192.42 | $255K | 0 |
| 2023-06-20 | Wang Julia Aijun Chief Financial Officer | Sale | −190 | $192.54 | $37K | 0 |
| 2023-06-20 | Wu Xiaobin President, COO & GM China | Sale | −1,753 | $192.44 | $337K | 0 |
| 2023-06-15 | Sanders Corazon (Corsee) D. Director | Grant or award | +12,922 | 37,414 | ||
| 2023-06-15 | Sanders Corazon (Corsee) D. Director | Grant or award · Share Option (Right to Buy) | +26,975 | 26,975 | ||
| 2023-06-15 | Riva Alessandro Director | Grant or award | +12,922 | 29,614 | ||
| 2023-06-15 | Riva Alessandro Director | Grant or award · Share Option (Right to Buy) | +26,975 | 26,975 | ||
| 2023-06-15 | Malley Thomas Director | Grant or award | +12,922 | 46,696 | ||
| 2023-06-15 | Malley Thomas Director | Grant or award · Share Option (Right to Buy) | +26,975 | 26,975 |
Page 42 of 71 · 1,406 trades